701 West Georgia Street
Vancouver, BC V7Y 1C6
Full Time Employees:
|Mr. Chung-Yu Wang B.Sc., EMBA, Ph.D.||Co-Founder, Chairman and Interim Chief Exec. Officer||N/A||N/A||71|
|Ms. Christina Yip MBA, BBA (Honours), CPA, CMA||Pres, Chief Financial Officer, Sec. and Director||N/A||N/A||52|
|Ms. Julie P. Rezler||VP of Corp. Devel.||N/A||N/A||N/A|
Pacgen Life Science Corporation, a life science company, focuses on commercializing life sciences products and services. It engages in the development, commercialization, and licensing of PAC-113, an antifungal that contains 12 amino-acid antimicrobial peptide derived from naturally occurring protein found in human saliva for the treatment of oral diseases, such as oral cavity, oral candidiasis, and esophagus infection. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.
Pacgen Life Science Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.